Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
Open Access
- 16 November 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Translational Psychiatry
- Vol. 11 (1), 1-8
- https://doi.org/10.1038/s41398-021-01724-w
Abstract
Drug repurposing is an invaluable strategy to identify new uses for existing drug therapies that overcome many of the time and financial costs associated with novel drug development. The COVID-19 pandemic has driven an unprecedented surge in the development and use of bioinformatic tools to identify candidate repurposable drugs. Using COVID-19 as a case study, we discuss examples of machine-learning and signature-based approaches that have been adapted to rapidly identify candidate drugs. The Library of Integrated Network-based Signatures (LINCS) and Connectivity Map (CMap) are commonly used repositories and have the advantage of being amenable to use by scientists with limited bioinformatic training. Next, we discuss how these recent advances in bioinformatic drug repurposing approaches might be adapted to identify repurposable drugs for CNS disorders. As the development of novel therapies that successfully target the cause of neuropsychiatric and neurological disorders has stalled, there is a pressing need for innovative strategies to treat these complex brain disorders. Bioinformatic approaches to identify repurposable drugs provide an exciting avenue of research that offer promise for improved treatments for CNS disorders.Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (RO1 MH107487, RO1MH121102)
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- U.S. Department of Health & Human Services | NIH | National Institute on Aging (RO1 AG057598)
This publication has 108 references indexed in Scilit:
- A vision and strategy for the virtual physiological human: 2012 updateInterface Focus, 2013
- Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based InferencePLoS Computational Biology, 2012
- ChEMBL: a large-scale bioactivity database for drug discoveryNucleic Acids Research, 2011
- PROMISCUOUS: a database for network-based drug-repositioningNucleic Acids Research, 2010
- The EuroPhysiome, STEP and a roadmap for the virtual physiological humanPhilosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2008
- DrugBank: a knowledgebase for drugs, drug actions and drug targetsNucleic Acids Research, 2007
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- Prospects for productivityNature Reviews Drug Discovery, 2004
- The Protein Data BankNucleic Acids Research, 2000